Mechanism of Action
Taurine circulates freely inside cells, without ever being incorporated into proteins. There it regulates water volume by controlling the movement of water and ions across membranes, a process called osmoregulation. This role matters for cells exposed to rapid environmental shifts.
In the liver, taurine conjugates with bile acids to form taurocholates. These compounds improve the solubilization of dietary fats and facilitate their intestinal absorption.
In the central nervous system, it binds to inhibitory receptors, the ones used by neurotransmitters associated with calm. This activity is described in laboratory work.
In the mitochondrion, the cell's energy plant, taurine takes part in the modification of certain transfer RNAs, the molecules that assemble proteins. This modification, called taurinylation, is involved in the working of the respiratory chain, the system that produces ATP.
Key Benefits
- Strong
Lower blood pressure: a synthesis of 34 controlled trials measures average reductions of 4.4 mmHg systolic and 2.5 mmHg diastolic, with the clearest effect between 1.5 and 3 g per day. The most rigorous of these trials followed 120 prehypertensive adults for 12 weeks, at 1.6 g per day.
- Strong
A better insulin response: three randomized placebo-controlled trials measure a reduction in fasting insulin and in the HOMA-IR index, which expresses insulin resistance. All three at 3 g per day for eight weeks, in adults whose fasting blood glucose was elevated.
- Moderate
Lower total cholesterol and LDL: three randomized placebo-controlled trials measure both reductions at 3 g per day for eight weeks, in adults whose fasting blood glucose was elevated and in women living with obesity.
- Moderate
Lower triglycerides: the synthesis of 34 trials measures an average reduction of 14.4 mg/dL. A randomized placebo-controlled trial finds it again at 3 g per day for seven weeks, in overweight young adults.
- Moderate
Improved endurance during exercise: a meta-analysis of ten trials reports a performance gain after a single intake of 1 to 6 g before exercise, measured in adults of varying training levels.
Dosage & Forms
Published human trials span a range of 0.2 to 10 g per day. The most recent analyses place the useful window for cardiometabolic markers between 1.5 and 3 g per day, with at least eight weeks for sugar and fat parameters. For endurance, a meta-analysis retains a single intake of 1 to 6 g before exercise.
The substance comes as a free taurine powder, purified to at least 98.5%, and that is the form used in the trials. The molecule has no chiral centre: the name "L-taurine" designates exactly the same thing. Magnesium taurate and homotaurine are distinct molecules, whose data do not carry over.
After ingestion, plasma taurine peaks within an hour and a half, then returns to its starting level within six to eight hours. It is absorbed with or without food.
On the regulatory side, Switzerland sets a maximum of 1,000 mg per recommended daily dose for food supplements; France and the United Kingdom set none.
In the Singular Formula
Inclusion rationale
Often mistaken for a stimulant because of its presence in energy drinks, taurine is in fact a sulfur amino acid that acts as an inhibitory neuromodulator in the central nervous system. It is one of the most abundant free amino acids in the human body, concentrated in organs with high metabolic demand: heart, brain, retina and skeletal muscle. Its place in the formula rests on a cardiometabolic base: a synthesis of 34 randomized trials measures reductions in blood pressure, total cholesterol, triglycerides and insulin resistance, within a window of 1.5 to 3 g per day. The most rigorous trial in that body of work followed 120 prehypertensive adults for 12 weeks. These three axes, blood pressure, blood lipids and blood glucose, are precisely the ones that drift over the decades. Synthesized in the body from cysteine, taurine also works in complementarity with NAC, likewise present in the formula, which supplies that precursor.
Selected form
Synthetic taurine suitable for vegetarian diets, a non-proteinogenic sulphur amino acid. Unlike the 20 protein amino acids, taurine is not incorporated into proteins: it remains free in tissues. It naturally concentrates in the heart, brain, retina and skeletal muscles. The body synthesises it from cysteine, and its dietary sources are almost exclusively animal. Obtained by chemical synthesis without animal-derived raw materials, it is chemically identical to natural taurine. Supplier-declared vegetarian suitability.
Formula dosage
0 to 3 g.
Dose expressed as active substance, excluding excipients and carriers of the raw material.
Synergies in the formula
Safety & Precautions
A published risk assessment retains 3 g per day as a safe intake level in healthy adults. The authorities that have examined the question place their benchmarks between 1 and 6 g per day depending on the method used, none having been able to identify a threshold for adverse effects in humans.
The discomforts reported in trials appear well above these doses: fatigue, drowsiness and reduced concentration from 10 g per day. One isolated case of hypersensitivity has been described in a person already allergic to sulfites and sulfonamides, taurine carrying the same sulfur group. Taurine is excluded from the formula when a sulfite allergy is declared.
Taurine is eliminated by the kidney, and accumulation has been reported in people on dialysis. Supplementation is not advised where kidney function is reduced.
In trials, taurine lowers blood pressure and blood glucose. People treated for either of these two parameters are invited to consult a healthcare professional before supplementing.
Supplementation is not advised during pregnancy and breastfeeding, for lack of exposure data in those situations. Taurine does not appear on the World Anti-Doping Agency list of prohibited substances.
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Nie Z et al. | 2025 | Meta-analysis | Nutrition Reviews | View on PubMed |
Effects of Oral Taurine Supplementation on Cardiometabolic Risk Factors: A Meta-analysis and Systematic Review of Randomized Clinical Trials Meta-analysis of 34 randomized trials. Measured reductions in systolic pressure (4.4 mmHg), triglycerides (14.4 mg/dL), total cholesterol (12.4 mg/dL), fasting blood glucose and the HOMA-IR index. Dose-response analyses place the effective window between 1.5 and 3 g per day. | ||||
| Sun Q et al. | 2016 | Randomised Controlled Trial | Hypertension | View on PubMed |
Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study Randomized, double-blind, placebo-controlled trial in 120 prehypertensive adults, 1.6 g per day for 12 weeks. Reduction in clinic and 24-hour ambulatory pressure, more marked in subjects with high-normal pressure, with improved vasodilation. | ||||
| Maleki V et al. | 2020 | Randomised Controlled Trial | Amino Acids | View on PubMed |
The effects of taurine supplementation on glycemic control and serum lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial Randomized, double-blind, placebo-controlled trial, 45 adults, 3 g per day for 8 weeks. Reductions in fasting blood sugar, insulin, HOMA-IR, total cholesterol and LDL. No change in glycated haemoglobin, triglycerides or HDL. | ||||
| Esmaeili F et al. | 2021 | Randomised Controlled Trial | Canadian Journal of Diabetes | View on PubMed |
The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial Randomized, double-blind, placebo-controlled trial, 46 adults, 3 g per day for 8 weeks. Reductions in fasting blood sugar, glycated haemoglobin, insulin, HOMA-IR, total cholesterol and LDL, along with two glycation markers. | ||||
| Moludi J et al. | 2022 | Randomised Controlled Trial | Nutrition & Metabolism | View on PubMed |
Protective and therapeutic effectiveness of taurine supplementation plus low calorie diet on metabolic parameters and endothelial markers in patients with diabetes mellitus: a randomized, clinical trial The largest trial conducted at this dose: 120 adults, 3 g per day for 8 weeks, all on a low-calorie diet. Reductions in insulin, HOMA-IR, C-reactive protein and endothelial markers. However, no effect on blood lipids, glycated haemoglobin or fasting blood glucose, which was nonetheless its primary endpoint. | ||||
| Waldron M et al. | 2018 | Meta-analysis | Sports Medicine | View on PubMed |
The Effects of an Oral Taurine Dose and Supplementation Period on Endurance Exercise Performance in Humans: A Meta-Analysis Meta-analysis of ten studies, doses of 1 to 6 g per day. A measured endurance gain, with the dose not moderating the effect within that range, and no difference between single intake and prolonged supplementation. | ||||
| Deng H et al. | 2025 | Meta-analysis | Scandinavian Journal of Medicine & Science in Sports | View on PubMed |
Does One Shot Work? The Acute Impact of a Single Taurine Dose on Exercise Performance: A Meta-Analytic Review A larger meta-analysis of 23 randomized trials, 308 participants. It finds a performance gain, but smaller than earlier work, with the certainty of evidence rated low to very low and prediction intervals that include no effect. | ||||
| Singh P et al. | 2023 | Cohort Study | Science | View on PubMed |
Taurine deficiency as a driver of aging Multi-species work. Supplementation extends lifespan in mice and worms, and healthspan in monkeys. The human part is purely observational: no participant was supplemented, and the authors conclude that clinical trials remain to be carried out. | ||||
| Fernandez ME et al. | 2025 | Cohort Study | Science | View on PubMed |
Is taurine an aging biomarker? Repeated measurements in the same individuals, across three geographically distinct human cohorts, plus primates and mice. Circulating taurine increases or remains stable with age. The authors conclude that its variation is not a universal feature of aging. | ||||
| Shao A, Hathcock JN | 2008 | Review | Regulatory Toxicology and Pharmacology | View on PubMed |
Risk assessment for the amino acids taurine, L-glutamine and L-arginine Risk assessment. Having been unable to identify a threshold for adverse effects in humans, the authors retain 3 g per day as the observed safe level in healthy adults. | ||||